Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113880781B reveals glucose-based route for triazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN117865874A details Pd-catalyzed olefin C-H amination for tetrahydroindole derivatives, offering high purity and scalable synthesis for pharmaceutical intermediates.
Patent CN106674178A reveals a metal-free DBU-catalyzed route for chromans, offering high yields and reduced environmental impact for reliable pharmaceutical intermediate suppliers.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and reduced operational hazards.
Patent CN114933570B reveals a mild copper-catalyzed route for 1,2,4-triazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for quinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115215783A details a novel copper-catalyzed synthesis of chiral propargyl-substituted oxindoles, offering high stereoselectivity and cost reduction in API manufacturing.
Catalyst-free patent CN107033073B enables green high-yield synthesis. Delivers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115260080B details a palladium-catalyzed route for indole-3-carboxamide. This method offers significant supply chain reliability and cost reduction advantages.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113880781B details glucose-based synthesis for trifluoromethyl-triazoles. This method offers mild conditions and scalable production for reliable pharmaceutical intermediates supply chains.
Discover a novel metal-free synthesis method for o-diamine compounds via alkenylsulfonium salts. Achieve cost reduction in API manufacturing with scalable, green chemistry.
Patent CN103224473B reveals solvent-free triazine ring synthesis. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Novel Pd-catalyzed method for Indole-3-carboxamide. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115925692A details a robust Rh-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109456180A reveals metal-free synthesis of β,β-dichlorolactone. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113735756A details a novel Rh-catalyzed [4+1] cyclization for high-purity chiral isoindolinones, offering significant cost reduction in API manufacturing.